Back in the 1970s, a group of physicians and scientists from Rennes University Hospital visited a fair focusing on the watchmaking and microtechniques industries in Besançon, in the hope of finding partners to develop tools for a new neurosurgery.

Prof. Scarabin and his team were working on SEEG, a new surgical technique to treat drug-resistant epilepsy that had been developed in the 1960s at St-Anne hospital in Paris with Prof. Talairach.

The collaboration between the neuroscientists and the precision industry experts blossomed over the years. DIXI took over in 1988. In the 1990s, the industrial production of the SEEG electrodes and implantation tools started. The French company slowly made its way outside of France. Since November 2017, DIXI medical products are FDA approved.

For more than 40 years, DIXI medical never ceased to innovate and improve its intracerebral electrodes and implantation accessories, working hand in hand with neurosurgeons and neurologists, and scientists from all around the world.


DIXI medical is part of the DIXI group. DIXI is a family-owned company founded in 1904 in the heart of the watch-making region in Switzerland.

The group is specialized in precision industry, microtechnology, and neurology. The group has five companies located in Switzerland and the neighboring French region of Franche-Comté.


DIXI medical is based since its beginnings in Besançon, France. The city is known as the capital of microtechnics; its know-how and expertise radiate worldwide.
In October 2018, DIXI medical inaugurated a new and bigger clean room.


DIXI medical can count on a cross-functional team of 80 highly skilled employees dedicated to making a difference in the life of epileptic patients worldwide.
DIXI medical is always looking for talents, from biomedical and design engineers to production operators, quality specialists, supply chain managers, and members of the commercials team. If you want to join us, check the job section!